Head of Investor Relations
Merck & Co., Inc. (MRK)Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsPeter Dannenbaum is recorded as Head of Investor Relations at Merck & Co., Inc. (MRK). Peter Dannenbaum has spoken on 25 earnings calls across 1 company, most recently for Merck & Co., Inc. on August 4, 2026. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer) and 7 others.
“Welcome to the second quarter 2026 conference call from Merck and Company Incorporated, Railway, New Jersey, USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer, Caroline Litchfield, Chief Financial Officer, and Dr. Dean Lee, President of Research Labs.”
“Welcome to the first quarter 2026 conference call for Merck and Company Incorporated, Railway, New Jersey, USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer, Caroline Litchfield, Chief Financial Officer, and Dr. Dean Lee, President of Research Labs.”
“Welcome to the fourth quarter 2025 conference call from Merkin Company, Incorporated, Railway, New Jersey, USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer, Caroline Litchfield, Chief Financial Officer, and Dr. Dean Lee, President of Research Labs.”
“Welcome to the Third Quarter 2025 Conference Call for Merck & Co, Inc., Rahway, New Jersey, U.S.A. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer; Caroline Litchfield, Chief Financial Officer; and Dr. Dean Li, President of Research Labs.”
“Welcome to the Second Quarter 2025 Conference Call for Merck & Co., Inc., Rahway, N.J., USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer; Caroline Litchfield, Chief Financial Officer; and Dr. Dean Li, President of Research Labs.”
Drug Manufacturers - General · Healthcare
Head of Investor Relations
